Zhu X, Stergiopoulos K, Wu S. Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis. AO [Internet]. 2009 Jan. 1 [cited 2024 Nov. 27];48(1):9-17. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25339